2014.1-8 FDA approved drug

2014.1-8 FDA approved drug

No.	Drug Name	Active Ingredient	Date	What It’s Used For
23.	Orbactiv	oritavancin	8/6/2014	To treat adults with skin  infections # k, b: |  b+ u  ^1 E  Press Release
22.	Jardiance	empagliflozin	8/1/2104	To improve gylcemic control  in adults with type 2 diabetes   Press Release
21.	Striverdi  Respimat	olodaterol	7/31/2014	To treat chronic obstructive  pulmonary disease 8 _$ q- o& t# T9 V8 g  Press Release
20.    + t1 O0 x$ m4 U+ v	Zydelig	idelalisib	7/23/2014	To treat patients with trhee  types of blood cancers ( z1 T# w+ q2 q& l7 |* u4 u; E( Q  Press Release
19.	Kerydin , A" Y9 H, [* M+ U+ ~- R	tavaborole	7/7/2014	For the topical treatment of  onychomycosis of the toenails 9 O4 V6 h$ ]% M8 c6 d# ~  (No Press Release)
18.	Beleodaq	belinostat	7/3/2014	To treat patients with  peripheral T-cell lymphoma (PTCL) * k& ~/ p) _8 ^- V* I9 c. I9 ^  Press Release
17.	Sivextro (tablet)Sivextro  (injection)	tedizolid phosphate	6/20/2014	To treat adults with skin  infections   Press Release
16.	Jublia 8 g4 Z3 b( j. T, G4 {) H   ! h% \. B0 ~" C: _" ^0 \2 {	efinaconazole	6/6/2014	Treat mild to moderate  onychomycosis (fungal infection) $ H" v: d8 ]) P9 T# R" X   No Press Release
15.	Dalvance , N  e0 r8 \3 B6 j+ h: Y   ) [) e- r) O, t8 w5 B9 g	dalbavancin	5/23/2014	To treat adults with skin  infections , |- C7 H8 u* Y4 k  Press Release
14.	Entyvio ! i7 `4 m1 b$ U( f	vedolizumab	5/20/2014	To treat adult patients with  moderate to severe ulcerative colitis and adult patients with moderate to  severe Crohn‘s disease . Z1 R6 k; }: c3 y# j3 A" a' e  Press Release
13.	Zontivity    ( Q! f9 h6 E# C$ D1 i' a' @	vorapaxar	5/8/2014	To reduce the risk of heart  attacks and stroke in high-risk patients & x" ?5 v: `; m1 E  h" Y$ f  Press Release
12.	Zykadia	ceritinib	4/29/2014	To treat patients with a  certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)   Press Release
11.	Sylvant	siltuximab	4/23/2014	To treat patients with multicentric  Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the  lymph nodes)   Press Release
10.	Cyramza	ramucirumab	4/21/2014	To treat patients with  advanced stomach cancer or gastroesophageal junction adenocarcinoma 2 m- [! S" c; g$ f" K4 B  Press Release
9.	Tanzeum	albiglutide	4/15/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes   Press Release
8.	Otezla	apremilast	3/21/2014	To treat adults with active  psoriatic arthritis (PsA) 1 _; e( b/ ~* Q  Press Release
7.	Impavido	miltefosine	3/19/2014	To treat a tropical disease  called leishmaniasis   Press Release
6.	Neuraceq	florbetaben F 18 injection	3/19/2014	For Positron  EmissionTomography (PET) imaging of the brain
5.	Myalept	metreleptin for injection	2/24/2014	To treat the complications  of leptin deficiency 7 N; v! }1 ^2 u+ G. E3 e  Press Release
4.	Northera	droxidopa	2/18/2014	To treat neurogenic  orthostatic hypotension (NOH) % W4 g$ X! {8 M. s* `/ }  Press Release
3.	Vimizim	elosulfase alfa	2/14/2014	Treatment for Mucopolysaccharidosis Type IVA  (Morquio A syndrome) ! K: A# u6 j9 d) u4 C; p2 O! o  Press Release
2.	Hetlioz	tasimelteon	1/31/2014	To treat non-24- hour sleep-wake disorder (“non-24”)  in totally blind individuals. Non-24 is a chronic circadian rhythm (body  clock) disorder in the blind that causes problems with the timing of sleep.Press Release
1.	Farxiga	dapaglifozin	1/8/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes   Press Release

* _& M  t6 }- J: b& V5 o1 Z& R

感谢楼主分享，楼主好强大